Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Elevance Health, Inc. (NYSE: ELV) against certain of their officers and directors for alleged breaches of fiduciary duty. Shareholders who have held shares continuously since prior to the dates listed below (where applicable) may have standing to seek corporate governance reforms focused on executive oversight, the return of funds to the Company, and a court-approved incentive award, at no cost to them.

If you are a long-term shareholder of Elevance Health, you may have standing to seek corporate governance reforms focused on executive oversight at Elevance.

To learn more, contact Johnson Fistel, PLLP at jimb@johnsonfistel.com or (619) 814-4471.

Complaint Allegations
A previously filed securities class action complaint alleges that during the period from April 18, 2024 through October 16, 2024, Defendants made materially false and/or misleading statements regarding Elevance’s Medicaid business. According to the complaint, Defendants failed to disclose that Medicaid redeterminations were driving higher-than-expected acuity and utilization among remaining members, that these cost trends were not adequately reflected in Elevance’s rate negotiations with states or in its financial guidance, and that, as a result, the Company’s public statements were materially false or misleading when made.

---